Clinical Trial Update: Breast Cancer Women on Aromatase Inhibitors Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update involving women with breast cancer treated with aromatase inhibitors. It focuses on osteoporosis and osteoporotic fractures, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Osteoporotic Fracture

Drugs mentioned

• Aromatase inhibitors (aromatase inhibitor)

Snippet

Sponsor: Parc de Salut Mar | Conditions: Osteoporosis, Osteoporosis Fracture | Phase 4 | Status: UNKNOWN